Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?

由 Zang, Rongyu, Zhu, Jianqing
發表在 J Gynecol Oncol (2019)

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation...

由 Chang, Ha Kyun, Kim, Byoung-Gie, Shi, Ting-Yan, Zang, Rongyu
發表在 J Gynecol Oncol (2016)

The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery

由 Cheng, Xi, Cai, Shumo, Li, Ziting, Tang, Meiqin, Xue, Muquan, Zang, Rongyu
出版 2004

Can 9q34.2 rs633862 polymorphism predict survival in epithelial ovarian cancer?

由 Jiang, Rong, Xu, Yuan, Wang, Pan, Cheng, Xi, Shi, Tingyan, Zang, Rongyu
發表在 PeerJ (2017)

Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling

由 Ji, Zhaodong, Tian, Wenjuan, Gao, Wen, Zang, Rongyu, Wang, Huaying, Yang, Gong
發表在 Front Cell Dev Biol (2021)

Current status of gynecological cancer in China

由 Kim, Kidong, Zang, Rongyu, Choi, Seok-Cheol, Ryu, Sang-Young, Kim, Jae Weon
出版 2009

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer

由 Shi, Tingyan, Jiang, Rong, Wang, Pan, Xu, Yuan, Yin, Sheng, Cheng, Xi, Zang, Rongyu
發表在 Onco Targets Ther (2017)

Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study

由 Ren, Yulan, Jiang, Rong, Yin, Sheng, You, Chao, Liu, Dongli, Cheng, Xi, Tang, Jie, Zang, Rongyu
發表在 BMC Cancer (2015)

AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway

由 Wang, Miao, Zhang, Lyu, Liu, Zeyang, Zhou, Jiamin, Pan, Qi, Fan, Jia, Zang, Rongyu, Wang, Lu
發表在 Cell Death Dis (2018)

Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis

由 Wang, Ziliang, Liu, Yang, Lu, Lili, Yang, Lina, Yin, Sheng, Wang, Yan, Qi, Zihao, Meng, Jiao, Zang, Rongyu, Yang, Gong
發表在 Oncotarget (2015)

The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy

由 Wang, Yan, Wang, Ziliang, Qi, Zihao, Yin, Sheng, Zhang, Na, Liu, Yang, Liu, Mingming, Meng, Jiao, Zang, Rongyu, Zhang, Zhen, Yang, Gong
出版 2014

An improved nerve-sparing radical hysterectomy technique for cervical cancer using the paravesico-vaginal space as a new surgical landmark

由 Zhang, Yuqin, Shi, Tingyan, Yin, Sheng, Ma, Sining, Shi, Di, Guan, Jun, Xiang, Libing, Liu, Yang, Ren, Yulan, Tan, Deyan, Zang, Rongyu
發表在 Oncotarget (2017)

Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling

由 Yin, Sheng, Wang, Pan, Yang, Lina, Liu, Yang, Wang, Yan, Liu, Mingming, Qi, Zihao, Meng, Jiao, Shi, Ting-Yan, Yang, Gong, Zang, Rongyu
發表在 Oncotarget (2016)

Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial

由 Shi, Tingyan, Jiang, Rong, Yu, Jinjin, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Shen, Yang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
發表在 Br J Cancer (2018)

Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study

由 Shi, Tingyan, Jiang, Rong, Pu, Hong, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Cai, Yunlang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
發表在 Br J Cancer (2019)

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept

由 Jiang, Rong, Zhu, Jianqing, Kim, Jae-Weon, Liu, Jihong, Kato, Kazuyoshi, Kim, Hee-Seung, Zhang, Yuqin, Zhang, Ping, Zhu, Tao, Aoki, Daisuke, Yu, Aijun, Chen, Xiaojun, Wang, Xipeng, Zhu, Ding, Zhang, Wei, Jia, Huixun, Shi, Tingyan, Gao, Wen, Yin, Sheng, Feng, Yanling, Xiang, Libing, Okamoto, Aikou, Zang, Rongyu
發表在 J Gynecol Oncol (2020)

A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study

由 Shi, Tingyan, Yin, Sheng, Zhu, Jianqing, Zhang, Ping, Liu, Jihong, Xiang, Libing, Zhu, Yaping, Wu, Sufang, Chen, Xiaojun, Wang, Xipeng, Teng, Yincheng, Zhu, Tao, Yu, Aijun, Zhang, Yingli, Feng, Yanling, Huang, He, Bao, Wei, Li, Yanli, Jiang, Wei, Zhang, Ping, Li, Jiarui, Ai, Zhihong, Zhang, Wei, Jia, Huixun, Zhang, Yuqin, Jiang, Rong, Zhang, Jiejie, Gao, Wen, Luan, Yuting, Zang, Rongyu
發表在 J Gynecol Oncol (2020)